Crossmark

Farnesoid X receptor (FXR) agonist ameliorates systemic insulin resistance, dysregulation of lipid metabolism, and alterations of various organs in a type 2 diabetic kidney animal model

Crossref DOI link: https://doi.org/10.1007/s00592-020-01652-z

Published Online: 2021-01-05

Published Print: 2021-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Han, Sang Youb

Song, Hye Kyoung

Cha, Jin Joo

Han, Jee Young

Kang, Young Sun.

Cha, Dae Ryong https://orcid.org/0000-0003-0063-2844
Funding

Funding for this research was provided by:

National Research Foundation of Korea (2017R1A2B2008862)

Aging Project (2017M3A9D8062955)
License Information

Text and Data Mining valid from 2021-01-05

Version of Record valid from 2021-01-05
More Information

Article History

Received: 15 September 2020

Accepted: 1 December 2020

First Online: 5 January 2021

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: Ethical approval was obtained from the Institutional Review Board of Korea University (KOREA-2017-0077).

: In this manuscript, no patient care was involved.

Document is current

Any future updates will be listed below